Antibacterial and therapeutic effects of vancomycin-resistant Staphylococcus aureus bacteriocin (VRSAcin) in the treatment of VRSA skin infection in mice
- 20 May 2025
- journal article
- Published by Elsevier in Microbial Pathogenesis
- Vol. 205, 107729
Abstract
No abstract availableKeywords
Funding Information
- King Khalid University (GRP/13/45)
This publication has 28 references indexed in Scilit:
- Bacteriocin isolated from Ralstonia mannitolilytica and bacteriocin-capped silver nanoparticles: Comparative effects on biofilm formation and LuxS Gene's expressions by Proteus mirabilis as an approach to counter MDR catheter infectionMicrobial Pathogenesis, 2025
- Evaluation the Antimicrobial Action of Kiwifruit Zinc Oxide Nanoparticles Against Staphylococcus aureus Isolated from Cosmetics ToolsBioNanoScience, 2023
- Phylogeny of hospital acquired MRSA, and its comparative phenotypic clinico-epidemiology with vancomycin resistant S. aureus (VRSA)Microbial Pathogenesis, 2020
- Mobilization of Microbiota Commensals and Their Bacteriocins for TherapeuticsTrends in Microbiology, 2019
- Predictors of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci co-colonization among nursing facility patientsAmerican Journal of Infection Control, 2019
- Using Ion Exchange Chromatography to Purify a Recombinantly Expressed Protein2014
- First case of infection with vancomycin-resistant Staphylococcus aureus in EuropeThe Lancet, 2013
- Lysostaphin: an antistaphylococcal agentApplied Microbiology and Biotechnology, 2008
- Progranulin is a mediator of the wound responseNature Medicine, 2003
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951